Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Due to limited data on the pathogenesis of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) and the suboptimal therapeutic effect, the development of new and effective treatment modalities was needed urgently. Low‐intensity extracorporeal shock wave therapy (Li‐ESWT) has been reported for the treatment of CP/CPPS. However, the underlying mechanism remains to be elucidated.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Objective</h3><p>To interrogated the efficacy and the mechanism of Li‐ESWT in the treatment of CP/CPPS.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Materials and Methods</h3><p>According to different treatments, RWPE‐1 cells (human prostate epithelial cells) were randomly divided into three groups: control group, LPS(lipopolysaccharide) group, or Li‐ESWT group (LPS induced RWPE‐1 managed by Li‐ESWT). Following the Li‐ESWT treatment, the levels of oxidative stress was assayed. We then established a rat model of experimental autoimmune prostatitis (EAP) by injecting prostatic protein homogenate mixed with complete Freund's adjuvant. The Sprague‐Dawley rats were randomly divided into the control group, EAP group, or Li‐ESWT group. Von Frey Filament was used to quantify pelvic hyperalgesia in the rats. Prostates tissues from each group were collected for immunohistochemistry, oxidation stress, and western blot analysis.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Histological analysis showed reduced inflammation and expression of cytokines (TNF‐α, IL‐1β, IL‐6, COX‐2, SP) in prostate tissues from the Li‐ESWT group compared with those from the EAP group (all <i>P</i> < 0.05). Similarly, there was reduced pelvic pain and allergic symptoms in the Li‐ESWT group compared with the EAP group (all <i>P</i> < 0.05). Besides, Li‐ESWT treatment could decrease oxidative stress in the prostate and in RWPE‐1 cells, respectively (both <i>P</i> < 0.05). Moreover, the Li‐ESWT up‐regulated the expression of CAT through the inhibition of phosphorylation of AKT/FOXO1 signaling pathway. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Discussion and Conclusions</h3><p>Li‐ESWT may reduce inflammation, oxidative stress and pain in rats with autoimmunity‐induced prostatitis via the PI3K/AKT/FOXO1 pathway. It implies that Li‐ESWT can present a potential therapeutic option for the treatment of CP/CPPS.</p></section>

Li‐ESWT treatment reduces inflammation, oxidative stress, and pain via the PI3K/AKT/FOXO1 pathway in autoimmune prostatitis rat models

The role of gut microbiota involved in prostate microenvironment and symptoms improvement in chronic prostatitis/chronic pelvic pain syndrome patients treated with low-intensity extracorporeal shock wave

Extracorporeal shock wave therapy decreases COX-2 by inhibiting TLR4-NFκB pathway in a prostatitis rat model

Safety of low-intensity extracorporeal shock wave therapy in prostate disorders: in vitro and in vivo evidence

Efficacy and safety of treating chronic nonspecific low back pain with radial extracorporeal shock wave therapy (rESWT), rESWT combined with celecoxib and eperisone (C + E) or C + E alone: a prospective, randomized trial

(273) Piezo Type-Eswt Alleviates Inflammation In The Rat Model Of Chronic Prostatitis

Extracorporeal shock wave therapy decreases the number of total and degranulated mast cells and alleviates pelvic pain in a rat model of prostatitis

Molecular Effects of Low-Intensity Shock Wave Therapy on L6 Dorsal Root Ganglion/Spinal Cord and Blood Oxygenation Level-Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Changes in Capsaicin-Induced Prostatitis Rat Models

Dietary habits and lifestyle related to the effectiveness of low-intensity extracorporeal shock wave therapy for chronic prostatitis/chronic pelvic pain syndrome-like symptoms: Initial results

Extracorporeal Shockwave Therapy (ESWT) Alleviates Pain, Enhances Erectile Function and Improves Quality of Life in Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Effect of Li-ESWT on Testicular Tissue and Function in Androgen-Deficient Rat Model

Sodium butyrate alleviates experimental autoimmune prostatitis by inhibiting oxidative stress and NLRP3 inflammasome activation via the Nrf2/HO‐1 pathway

Isoliquiritigenin reduces experimental autoimmune prostatitis by facilitating Nrf2 activation and suppressing the NLRP3 inflammasome pathway

(254) Extracorporeal Shock Wave Therapy Combined with Cannabidiol Reduces Prostatic Inflammation by Regulating TLR4-NFκB Signaling Pathway

Hedyotis diffusa Willd inhibits inflammation and oxidative stress to protect against chronic prostatitis via the NRF2/ARE signaling pathway

Low-Energy Shock Wave Suppresses Prostatic Pain and Inflammation by Modulating Mitochondrial Dynamics Regulators on a Carrageenan-Induced Prostatitis Model in Rats

Astaxanthin Alleviates Chronic Prostatitis via the ERK1/2 Signaling Pathway: Evidence from Network Pharmacology and Experimental Validation

Lycopene attenuates chronic prostatitis/chronic pelvic pain syndrome by inhibiting oxidative stress and inflammation via the interaction of NF-κB, MAPKs, and Nrf2 signaling pathways in rats

Lycopene attenuates chronic prostatitis/chronic pelvic pain syndrome by inhibiting oxidative stress and inflammation via the interaction of NF-B, MAPKs, and Nrf2 signaling pathways in rats

Influence of Experimental Autoimmune Prostatitis on Sexual Function and the Anti-inflammatory Efficacy of Celecoxib in a Rat Model

Radial Extracorporeal Shock Wave Therapy Combined with Resveratrol Derivative Alleviates Chronic Nonbacterial Prostatitis in Rats